Reacting to “an emerging human disaster,” the University of Pittsburgh Graduate School of Public Health will match a $200,000 private donation in efforts to raise $1 million for a research collaboration with a Brazilian counterpart to address the Zika virus epidemic.

A better understanding of Zika’s impact on health could lead to methods to prevent, treat and even cure Zika viral infections.

During a Cura Zika (Cure Zika) conference Thursday, Donald S. Burke, dean of Pitt Public Health, introduced five noted researchers, each of whom outlined projects to track and mitigate infections, develop a vaccine and find ways to block the virus from breaching the barrier in the placenta to cause neurological damage in newborns.

“There’s no limit to the type of research we can do — from diagnostics, to vaccines, to the care of patients, and the pathogenesis of Zika,” Dr. Burke said. “Everything is in play.”

Advertise with us

Zika is a mosquito-borne virus that also can be transmitted sexually. It can cause microcephaly — a neurological condition leading to a small head and brain — in infants born to mothers infected with it. It also can increase the risk of Guillain-Barre syndrome and other neurological disorders in people with infections. Zika infections are spreading quickly throughout South and Central America and Caribbean islands.

Development of a Zika vaccine has potential through the work of Ernesto Marques, an associate professor in Pitt Public Health’s department of infectious diseases and microbiology. He has already helped develop a dengue vaccine now in use with dengue representing a flavovirus similar to Zika. Given that background, he said, there’s “no foreseeable obstacle” in creating a Zika vaccine.

Dr. Marques, who has a research laboratory in Brazil, is the direct link with the Brazilian Ministry of Health’s Fundacao Oswald Cruz Foundation, which is collaborating with Pitt in the Cura Zika project.

David Templeton: 412-263-1578 or dtempleton@post-gazette.com.